v3.26.1
CONDENSED STATEMENTS OF OPERATIONS - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Jun. 30, 2026
Jun. 30, 2025
Operating expenses:        
Research and development $ 1,833 $ 1,541 $ 3,028 $ 3,730
General and administrative 1,251 1,164 2,582 2,369
Total operating expenses 3,084 2,705 5,610 6,099
Loss from operations (3,084) (2,705) (5,610) (6,099)
Other income (expense):        
Interest income 77 17 171 33
Other (expense) income, net 0 151 (2) 182
Net loss $ (3,007) $ (2,537) $ (5,441) $ (5,884)
Loss per share, basic (in dollars per share) $ (1.11) $ (3.36) $ (2.08) $ (8.64)
Loss per share, diluted (in dollars per share) $ (1.11) $ (3.36) $ (2.08) $ (8.64)
Weighted average number of shares of common stock, basic (in shares) 2,706,607 754,725 2,620,740 681,235
Weighted average number of shares of common stock, diluted (in shares) 2,706,607 754,725 2,620,740 681,235